Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in Triple Negative Breast Cancer clinical trials, as well as the reasons for withdrawal or discontinuation.

The insights gained from this study will ultimately benefit those with Triple Negative Breast Cancer who may be invited to participate in clinical research in the years to come.

Inclusion Criteria:

• Age ≥ 18 years
• Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
• Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol

Exclusion Criteria:

• Pregnant or lactating woman
• Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
• Inability to perform regular electronic reporting

Triple negative breast cancer patients who are actively considering participating in an observational medical study, but have not yet completed enrollment and randomization.